Klisovic, R. B., Blum, W., Liu, Z., Xie, Z., Kefauver, C., Huynh, L., . . . Marcucci, G. (2013). Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia. Leuk Lymphoma.
Citação norma ChicagoKlisovic, Rebecca B., et al. "Phase I Study of GTI-2040, a Ribonucleotide Reductase Antisense, With High Dose Cytarabine in Patients With Relapsed/refractory Acute Myeloid Leukemia." Leuk Lymphoma 2013.
Citação norma MLAKlisovic, Rebecca B., et al. "Phase I Study of GTI-2040, a Ribonucleotide Reductase Antisense, With High Dose Cytarabine in Patients With Relapsed/refractory Acute Myeloid Leukemia." Leuk Lymphoma 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.